ventions for myopia control in children  : a network meta-analysis.
Ophthalmology 2016 ; 123(4) : 697-708.
[24] Polling JR, Kok RGW, Tideman JWL, et al. Effectiveness study
of atropine for progressive myopia in Europeans. Eye Lond Engl
2016 ; 30(7) : 998-1004.
[25] Li SM, Wu SS, Kang MT, et al. Atropine slows myopia progres-
sion more in Asian than white children by meta-analysis. Optom Vis
Sci 2014 ; 91(3) : 342-50.
[26] Siatkowski RM, Cotter SA, Crockett RS, et al. Two-year mul-
ticenter, randomized, double-masked, placebo-controlled, parallel
safety and efficacy study of 2 % pirenzepine ophthalmic gel in child-
ren with myopia. J AAPOS 2008 ; 12(4) : 332-9.
[27] Tan S, Yu M, Baig N, et al. Circadian intraocular pressure fluc-
tuation and disease progression in primary angle closure glaucoma.
Investig Opthalmology Vis Sci 2015 ; 56(8) : 4994.
[28] Sun Y, Xu F, Zhang T, et al. Orthokeratology to control myopia
progression : a meta-analysis. PloS One 2015 ; 10(4) : e0124535.
[29] Reim T, Lund M, Wu R. Orthokeratology and adolescent myo-
pia control. Contact Lens Spectr 2003 ; 18(3) : 40-2.
[30] Cho P, Cheung SW, Edwards M. The longitudinal orthokerato-
logy research in children (LORIC) in Hong Kong : a pilot study on
refractive changes and myopic control. Curr Eye Res 2005 ; 30(1) :